| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |